Articles

Poll

Podcasts

Slideshows

Videos

Nephrology

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Experts outline a 2026 vision for glomerular disease care, including new endpoints, combination therapies, and gene therapy advances.

Clinical Trial Summit 2026: Advanced Therapies, Equity, Global Outlook For Glomerular Diseases

The PARASOL initiative is reshaping glomerular disease trials through shared data and improved surrogate endpoints.

PARASOL, Endpoints, and Rethinking Clinical Trials in Glomerular Disease

PLA2R antibodies are advancing precision care in membranous nephropathy and informing new surrogate endpoints through PARASOL.

PLA2R, Membranous Nephropathy, and the PARASOL Membranous Project

Anti-nephrin autoantibodies are redefining minimal change disease and enabling more precise, steroid-sparing treatment strategies.

Anti-Nephrin Autoantibodies, Precision in Nephrotic Syndrome

APOL1 kidney disease highlights the need for community trust, increased screening, and stronger clinical trial participation.

APOL1 Kidney Disease: Community, Trust, and Trial Participation

Rapid advances in glomerular disease, from single-cell tech to biomarkers and phase 3 trials, are reshaping diagnosis and treatment.

ISGD and the Fastest 5 Years in Glomerular Disease

FDA-approved iptacopan and pegcetacoplan offer new complement-targeted therapies for C3 glomerulopathy.

Complement Inhibitors Reshape Treatment Landscape for C3 Glomerulopathy, With Sayna Norouzi

Norouzi discusses a recent review where 11 clinicians described C3G pathology and diagnosis.  

Deep Diving into the Pathogenesis of C3 Glomerulopathy, With Sayna Norouzi

On Rare Disease Day 2026, clinicians share their perspective on the evolving landscape for IgAN and C3G. 

Rare Disease Day 2026: Kidney Diseases Enter Optimistic Therapeutic Era

Quarter 4 2025 showed robust advancements in the nephrology field, including FDA news, trial updates, and featured content. 

Q4 2025 Recap: Nephrology News and Updates

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.